SMARCA4 and rhabdoid tumor: From a molecular perspective, accumulating evidence indicates that ovarian small-cell carcinomas, particularly the hypercalcemic type, almost universally carry deleterious SMARCA4 mutations, leading to their reclassification as malignant rhabdoid tumors within the same pathological spectrum (16–18).